Trademark Overview
On Monday, May 5, 2025, a trademark application was filed for XONGEVRI with the United States Patent and Trademark Office. The USPTO has given the XONGEVRI trademark a serial number of 99170040. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, July 15, 2025. This trademark is owned by Pfizer Inc.. The XONGEVRI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.
